Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B cell activity refers to the processes by which B lymphocytes (B cells) recognize antigens, become activated, proliferate, and differentiate into effector cells that mediate humoral immunity. B cells are a critical component of the adaptive immune system and are primarily responsible for producing antibodies to neutralize pathogens. This encompasses antigen recognition via the B-cell receptor (BCR), T cell-dependent and T cell-independent activation pathways, differentiation into plasmablasts, plasma cells, and memory B cells, and the secretion of antibodies.
N/A
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B Cell Activity (N/A).